These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 17334909)

  • 61. Functional aspects of membrane folate receptors in human breast cancer cells with transport-related resistance to methotrexate.
    Pinard MF; Jolivet J; Ratnam M; Kathmann I; Molthoff C; Westerhof R; Schornagel JH; Jansen G
    Cancer Chemother Pharmacol; 1996; 38(3):281-8. PubMed ID: 8646804
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Defective transport is a common mechanism of acquired methotrexate resistance in acute lymphocytic leukemia and is associated with decreased reduced folate carrier expression.
    Gorlick R; Goker E; Trippett T; Steinherz P; Elisseyeff Y; Mazumdar M; Flintoff WF; Bertino JR
    Blood; 1997 Feb; 89(3):1013-8. PubMed ID: 9028333
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Membrane transport of folates.
    Matherly LH; Goldman DI
    Vitam Horm; 2003; 66():403-56. PubMed ID: 12852262
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Oligomeric structure of the human reduced folate carrier: identification of homo-oligomers and dominant-negative effects on carrier expression and function.
    Hou Z; Matherly LH
    J Biol Chem; 2009 Jan; 284(5):3285-3293. PubMed ID: 19019821
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Cellular and molecular mechanisms of resistance to antifolate drugs: new analogues and approaches to overcome the resistance.
    Takemura Y; Kobayashi H; Miyachi H
    Int J Hematol; 1997 Dec; 66(4):459-77. PubMed ID: 9479873
    [TBL] [Abstract][Full Text] [Related]  

  • 66. A humanized mouse model for the reduced folate carrier.
    Patterson D; Graham C; Cherian C; Matherly LH
    Mol Genet Metab; 2008 Feb; 93(2):95-103. PubMed ID: 17983788
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Reduced folate carrier gene expression in childhood acute lymphoblastic leukemia: relationship to immunophenotype and ploidy.
    Zhang L; Taub JW; Williamson M; Wong SC; Hukku B; Pullen J; Ravindranath Y; Matherly LH
    Clin Cancer Res; 1998 Sep; 4(9):2169-77. PubMed ID: 9748136
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Antifolates in cancer therapy: structure, activity and mechanisms of drug resistance.
    Gonen N; Assaraf YG
    Drug Resist Updat; 2012 Aug; 15(4):183-210. PubMed ID: 22921318
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Selective preservation of pemetrexed pharmacological activity in HeLa cells lacking the reduced folate carrier: association with the presence of a secondary transport pathway.
    Zhao R; Hanscom M; Chattopadhyay S; Goldman ID
    Cancer Res; 2004 May; 64(9):3313-9. PubMed ID: 15126375
    [TBL] [Abstract][Full Text] [Related]  

  • 70. The inverse relationship between reduced folate carrier function and pemetrexed activity in a human colon cancer cell line.
    Chattopadhyay S; Zhao R; Krupenko SA; Krupenko N; Goldman ID
    Mol Cancer Ther; 2006 Feb; 5(2):438-49. PubMed ID: 16505119
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Cellular aspects of folate and antifolate membrane transport.
    Brzezińska A; Wińska P; Balińska M
    Acta Biochim Pol; 2000; 47(3):735-49. PubMed ID: 11310973
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Residues 45 and 404 in the murine reduced folate carrier may interact to alter carrier binding and mobility.
    Zhao R; Wang Y; Gao F; Goldman ID
    Biochim Biophys Acta; 2003 Jun; 1613(1-2):49-56. PubMed ID: 12832086
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Folate coenzyme and antifolate transport proteins in normal and neoplastic cells.
    Freisheim JH; Price EM; Ratnam M
    Adv Enzyme Regul; 1989; 29():13-26. PubMed ID: 2561247
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Rodent intestinal folate transporters (SLC46A1): secondary structure, functional properties, and response to dietary folate restriction.
    Qiu A; Min SH; Jansen M; Malhotra U; Tsai E; Cabelof DC; Matherly LH; Zhao R; Akabas MH; Goldman ID
    Am J Physiol Cell Physiol; 2007 Nov; 293(5):C1669-78. PubMed ID: 17898134
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Gene amplification and increased expression of the reduced folate carrier in transport elevated K562 cells.
    Wong SC; Zhang L; Proefke SA; Hukku B; Matherly LH
    Biochem Pharmacol; 1998 Apr; 55(7):1135-8. PubMed ID: 9605439
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Folate transport and the modulation of antifolate sensitivity in a methotrexate-resistant human breast cancer cell line.
    Dixon KH; Trepel JB; Eng SC; Cowan KH
    Cancer Commun; 1991; 3(12):357-65. PubMed ID: 16296001
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Methylation-dependent silencing of the reduced folate carrier gene in inherently methotrexate-resistant human breast cancer cells.
    Worm J; Kirkin AF; Dzhandzhugazyan KN; Guldberg P
    J Biol Chem; 2001 Oct; 276(43):39990-40000. PubMed ID: 11509559
    [TBL] [Abstract][Full Text] [Related]  

  • 78. A novel cDNA restores reduced folate carrier activity and methotrexate sensitivity to transport deficient cells.
    Dixon KH; Lanpher BC; Chiu J; Kelley K; Cowan KH
    J Biol Chem; 1994 Jan; 269(1):17-20. PubMed ID: 8276792
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Nuclear respiratory factor 1 (NRF-1) upregulates the expression and function of reduced folate carrier (RFC) at the blood-brain barrier.
    Alam C; Hoque MT; Sangha V; Bendayan R
    FASEB J; 2020 Aug; 34(8):10516-10530. PubMed ID: 32543769
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Internalization of Methotrexate Conjugates by Folate Receptor-α.
    Nogueira E; Sárria MP; Azoia NG; Antunes E; Loureiro A; Guimarães D; Noro J; Rollett A; Guebitz G; Cavaco-Paulo A
    Biochemistry; 2018 Dec; 57(49):6780-6786. PubMed ID: 30452231
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.